| Literature DB >> 21435205 |
Anna Granlund1, Marianne Jensen-Waern, Birgitta Essén-Gustavsson.
Abstract
BACKGROUND: AMP-activated protein kinase (AMPK) plays an important role in the regulation of glucose and lipid metabolism in skeletal muscle. Many pigs of Hampshire origin have a naturally occurring dominant mutation in the AMPK γ3 subunit. Pigs carrying this PRKAG3 (R225Q) mutation have, compared to non-carriers, higher muscle glycogen levels and increased oxidative capacity in m. longissimus dorsi, containing mainly type II glycolytic fibres. These metabolic changes resemble those seen when muscles adapt to an increased physical activity level. The aim was to stimulate AMPK by exercise training and study the influence of the PRKAG3 mutation on metabolic and fibre characteristics not only in m. longissimus dorsi, but also in other muscles with different functions.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21435205 PMCID: PMC3076241 DOI: 10.1186/1751-0147-53-20
Source DB: PubMed Journal: Acta Vet Scand ISSN: 0044-605X Impact factor: 1.695
Figure 1Photomicrographs of serial sections of . Fibre types I, IIA, and IIB classified with myosin ATPase (pH 4.6) stains (A, D) and fibre type IIAX is classified with immunohistochemical (A4-74) stains (B, E). Note that many type IIB fibres in the myosin ATPase stain were classified as IIAX fibres with the immunohistochemical stain and that some of these IIAX fibres may be pure, IIX or IIBX fibres. Oxidative capacity is evaluated from the NADH tetrazolium reductase stains (C, F). Note that type I fibres have a high staining intensity, whereas staining intensity varies among the subgroups of type II fibres.
Fibre characteristics in different muscle groups in carriers and non-carriers of the PRKAG3 mutation.
| Carriers (n = 7) | Non-carriers (n = 7) | Carriers (n = 7) | Non-carriers (n = 7) | |
|---|---|---|---|---|
| Fibre type (%) | ||||
| I | 27 ± 1 | 24 ± 1 | 15 ± 1 | 13 ± 1 |
| IIA | 7 ± 1 | 8 ± 1 | 4 ± 1 | 2 ± 1 |
| IIAX | 37 ± 2 | 33 ± 2 | 56 ± 3 * | 38 ± 3 |
| IIB | 29 ± 1 * | 35 ± 1 | 25 ± 2 * | 47 ± 3 |
| Fibre area (μm2) | ||||
| I | 2471 ± 194 * | 1896 ± 146 | 2571 ± 196 * | 1965 ± 192 |
| IIA | 3346 ± 330 * | 2424 ± 173 | 2118 ± 326 | 1949 ± 426 |
| IIAX | 5443 ± 399 * | 3352 ± 276 | 5088 ± 430 * | 3856 ± 354 |
| IIB | 7054 ± 592 * | 5224 ± 500 | 4630 ± 396 | 4576 ± 229 |
| Relative fibre area (%) | ||||
| I | 15 ± 2 | 14 ± 1 | 9 ± 1 | 6 ± 1 |
| IIA | 5 ± 1 | 6 ± 1 | 2 ± 1 | 2 ± 1 |
| IIAX | 41 ± 2 * | 33 ± 2 | 65 ± 3 * | 39 ± 3 |
| IIB | 39 ± 3 * | 47 ± 1 | 25 ± 3 * | 53 ± 4 |
| NADH intensity (%) | ||||
| I High | 100 ± 0 | 100 ± 0 | 100 ± 0 | 100 ± 0 |
| IIA High | 12 ± 6 | 12 ± 5 | 17 ± 17 | 0 ± 0 |
| IIA Medium | 88 ± 6 | 88 ± 5 | 83 ± 17 | 100 ± 0 |
| IIAX Medium | 57 ± 4 * | 92 ± 3 | 25 ± 4 * | 61 ± 6 |
| IIAX Low | 43 ± 4 * | 8 ± 3 | 75 ± 4 * | 39 ± 6 |
| IIB Medium | 2 ± 1 | 2 ± 1 | 13 ± 3 * | 4 ± 2 |
| IIB Low | 98 ± 1 | 98 ± 1 | 87 ± 3 * | 96 ± 2 |
Fibre type composition was identified with myosin ATPase stains and type I and IIA+ IIX with myosin heavy chain antibodies.
NADH-tetrazolium reductase staining intensity was subjectively evaluated as low, medium and high in the different fibre types.
Data as means ± SE. * P < 0.05 significantly different to non-carriers.
Fibre characteristics in different muscle groups in carriers and non-carriers of the PRKAG3 mutation.
| Carriers (n = 7) | Non-carriers (n = 6) | Carriers (n = 7) | Non-carriers (n = 7) | |
|---|---|---|---|---|
| Fibre type (%) | ||||
| I | 16 ± 1 | 13 ± 4 | 28 ± 4 | 32 ± 4 |
| IIA | 4 ± 1 | 6 ± 1 | 70 ± 3 | 67 ± 4 |
| IIB | 80 ± 1 | 81 ± 4 | 2 ± 0 | 1 ± 1 |
| Fibre area (μm2) | ||||
| I | 2388 ± 118 | 2386 ± 228 | 1659 ± 186 | 2142 ± 235 |
| IIA | 2574 ± 402 | 2905 ± 380 | 2127 ± 302 | 2264 ± 266 |
| IIB | 4574 ± 285 | 4504 ± 446 | 1429 ± 175 | 2192 ± 181 |
| Relative fibre area (%) | ||||
| I | 9 ± 1 | 8 ± 1 | 24 ± 4 | 31 ± 4 |
| IIA | 3 ± 1 | 4 ± 0 | 74 ± 4 | 68 ± 4 |
| IIB | 88 ± 1 | 88 ± 1 | 1 ± 0 | 2 ± 1 |
Fibre type composition was identified using myosin ATPase stains.
Data as means ± SE.
Enzyme activities and glycogen concentration in different muscle groups in carriers and non-carriers of the PRKAG3 mutation.
| Carriers (n = 6) | Non-carriers (n = 6) | Carriers (n = 6) | Non-carriers (n = 7) | Carriers (n = 7) | Non-carriers (n = 7) | |
|---|---|---|---|---|---|---|
| CS | 20 ± 3 | 8 ± 5 | 15 ± 1 | 13 ± 2 | 19 ± 2 | 20 ± 1 |
| HAD | 24 ± 1 | 24 ± 2 | 26 ± 2 | 26 ± 2 | 31 ± 3 | 29 ± 3 |
| HK | 8 ± 1 * | 3 ± 2 | 7 ± 1 * | 4 ± 1 | 8 ± 1 * | 5 ± 1 |
| Phosphorylase | 18 ± 2 * | 15 ± 2 | 17 ± 2 | 15 ± 3 | 16 ± 2 * | 11 ± 1 |
| LDH | 2778 ± 328 * | 3199 ±134 | 2929 ± 187 * | 3255 ± 203 | 2474 ± 219 | 2561 ± 179 |
| Glycogen | 725 ± 46 * | 458 ± 32 | 600 ± 49 * | 349 ± 18 | 681 ± 42 * | 420 ± 28 |
Data are expressed as mmol/kg/min for citrate synthase (CS), 3-hydroxyacyl-CoA (HAD), hexokinase (HK), phosphorylase, lactate dehydrogenase (LDH) and in mmol/kg for glycogen concentration.
Data as means ± SE. * P < 0.05 significantly different from non-carriers.